title: Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein.
abstract: Clostridium perfringens infections are characterized by the lack of an inflammatory response at the site of infection and rapidly progressive margins of tissue necrosis. Studies presented here investigated the role of theta toxin from C. perfringens in the pathophysiology of these events. Mice passively immunized with neutralizing monoclonal antibody against theta toxin and challenged with an LD100 of log phase C. perfringens had significantly less mortality than untreated controls. Intramuscular injection of killed, washed C. perfringens in mice induced a massive time-dependent influx of polymorphonuclear leukocytes (PMNL) into tissue; injection of either viable, washed C. perfringens or killed organisms plus theta toxin dramatically attenuated PMNL influx although PMNL accumulated in adjacent vessels. The anti-inflammatory effects could not be attributed to an absence of chemoattractants since C. perfringens proteins had chemotactic factor activity, and killed bacilli generated serum-derived chemotactic factors. Scanning and transmission electron microscopy demonstrated the dramatic leukocidal effects of high doses of theta toxin on PMNL. In contrast, sublethal concentrations of theta toxin primed PMNL chemiluminescence, disrupted PMNL cytoskeletal actin polymerization/disassembly, and stimulated functional upregulation of CD11b/CD18 adherence glycoprotein. In summary, these results demonstrate that theta toxin is an important virulence factor in C. perfringens infection. In a concentration-dependent fashion, theta toxin contributes to the pathogenesis of clostridial gangrene by direct destruction of host inflammatory cells and tissues, and by promoting dysregulated PMNL/endothelial cell adhesive interactions.
authors.affiliation: Infectious Diseases Section, Veterans Affairs Medical Center, Boise, ID 83702.
authors.forename: A E
authors.initials: AE
authors.lastname: Bryant
authors.forename: R
authors.initials: R
authors.lastname: Bergstrom
authors.forename: G A
authors.initials: GA
authors.lastname: Zimmerman
authors.forename: J L
authors.initials: JL
authors.lastname: Salyer
authors.forename: H R
authors.initials: HR
authors.lastname: Hill
authors.forename: R K
authors.initials: RK
authors.lastname: Tweten
authors.forename: H
authors.initials: H
authors.lastname: Sato
authors.forename: D L
authors.initials: DL
authors.lastname: Stevens
mesh_terms: D000199:Actins / Q000378:metabolism; D000328:Adult; D000818:Animals; D015703:Antigens, CD / Q000032:analysis*; D001427:Bacterial Toxins / Q000633:toxicity*; D018845:CD11 Antigens; D018821:CD18 Antigens; D002634:Chemotaxis, Leukocyte; D003015:Clostridium Infections / Q000276:immunology / Q000473:pathology; D003016:Clostridium perfringens / Q000472:pathogenicity*; D005260:Female; D006460:Hemolysin Proteins / Q000633:toxicity*; D006801:Humans; D008297:Male; D051379:Mice; D009504:Neutrophils / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure
chemical_list: D000199:Actins; D015703:Antigens, CD; D001427:Bacterial Toxins; D018845:CD11 Antigens; D018821:CD18 Antigens; D006460:Hemolysin Proteins; C020452:Clostridium perfringens theta-toxin